Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Pietroluongo

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|September 14, 2023
Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune responseGustavo Cernera, Monica Gelzo, Pietro De Placido, et al.
Frontiers in Immunology|July 19, 2024
Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitorAngelo Luciano, Erica Pietroluongo, Margaret Ottaviano, et al.
Critical Reviews in Oncology/Hematology|September 26, 2024
DLL3 as a potential diagnostic and therapeutic target in neuroendocrine neoplasms: A narrative reviewAnnarita Peddio, Erica Pietroluongo, Maria Rosaria Lamia, et al.
AME Case Reports|November 7, 2022
The unusual first sign of presentation of renal cell carcinoma: a rare case reportRocco Morra, Antonio D'Ambrosio, Erica Pietroluongo, et al.
Biomedicines|March 29, 2023
Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma ArchetypeAldo Caltavituro, Roberto Buonaiuto, Erica Pietroluongo, et al.
Journal of Clinical Immunology|July 4, 2026
Immunopathological Profile of Patients with Thymic Epithelial Tumour and Good Syndrome in Advanced StageFabiana Napolitano, Erica Pietroluongo, Michele Francesco Di Tolla, et al.
Frontiers in Immunology|December 10, 2025
Circulating innate lymphoid cells and IL-18 as potential immune biomarkers in thymic tumorsDaniela Claudia Maresca, Maria Rosaria Saponaro, Evelina La Civita, et al.
Frontiers in Oncology|September 5, 2022
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational studyPietro De Placido, Erica Pietroluongo, Carmine De Angelis, et al.
Frontiers in Oncology|February 13, 2023
Extraskeletal Ewing's sarcoma of the mediastinum: Case reportAldo Caltavituro, Roberto Buonaiuto, Fabio Salomone, et al.
Therapeutic Advances in Medical Oncology|February 16, 2026
Impact of relative dose intensity of first-line platinum-based chemotherapy in patients with thymic epithelial tumors: a retrospective studyErica Pietroluongo, Pietro De Placido, Roberto Buonaiuto, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|September 14, 2023
Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune responseGustavo Cernera, Monica Gelzo, Pietro De Placido, et al.
Frontiers in Immunology|July 19, 2024
Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitorAngelo Luciano, Erica Pietroluongo, Margaret Ottaviano, et al.
Critical Reviews in Oncology/Hematology|September 26, 2024
DLL3 as a potential diagnostic and therapeutic target in neuroendocrine neoplasms: A narrative reviewAnnarita Peddio, Erica Pietroluongo, Maria Rosaria Lamia, et al.
AME Case Reports|November 7, 2022
The unusual first sign of presentation of renal cell carcinoma: a rare case reportRocco Morra, Antonio D'Ambrosio, Erica Pietroluongo, et al.
Biomedicines|March 29, 2023
Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma ArchetypeAldo Caltavituro, Roberto Buonaiuto, Erica Pietroluongo, et al.
Journal of Clinical Immunology|July 4, 2026
Immunopathological Profile of Patients with Thymic Epithelial Tumour and Good Syndrome in Advanced StageFabiana Napolitano, Erica Pietroluongo, Michele Francesco Di Tolla, et al.
Frontiers in Immunology|December 10, 2025
Circulating innate lymphoid cells and IL-18 as potential immune biomarkers in thymic tumorsDaniela Claudia Maresca, Maria Rosaria Saponaro, Evelina La Civita, et al.
Frontiers in Oncology|September 5, 2022
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational studyPietro De Placido, Erica Pietroluongo, Carmine De Angelis, et al.
Frontiers in Oncology|February 13, 2023
Extraskeletal Ewing's sarcoma of the mediastinum: Case reportAldo Caltavituro, Roberto Buonaiuto, Fabio Salomone, et al.
Therapeutic Advances in Medical Oncology|February 16, 2026
Impact of relative dose intensity of first-line platinum-based chemotherapy in patients with thymic epithelial tumors: a retrospective studyErica Pietroluongo, Pietro De Placido, Roberto Buonaiuto, et al.
Pageof 4